Kelyniam Global

Kelyniam Global’s CFO, Terrance Kurtenbach, will present at the Life Sciences Virtual Investor Forum on September 18, 2025, at 10:00 AM EDT. The forum allows investors to learn about Kelyniam’s growth strategy and innovative custom cranial implants leveraging CAD/CAM technology and advanced medical-grade polymers. Management will be available for one-on-one meetings. Kelyniam focuses on personalized solutions and is expanding into regenerative medicine with licensed products.